摘要:
The invention provides a method of preventing or treating cancer in a subject by administering to the subject a therapeutically effective amount of a GPR84 antagonist. Also provided is a method of preventing recurrence of cancer in a subject by administering to the subject a therapeutically effective amount of a GPR84 antagonist. Further, the invention provides a method of modulating the immune system of a subject afflicted with or at risk of cancer by administering to the subject a therapeutically effective amount of a GPR84 antagonist. Still further, the invention provides a method of preventing or treating an inflammatory response in a subject by administering to the subject a therapeutically effective amount of a GPR84 agonist. Also provided is a method of preventing an immune system disease or disorder in a subject by administering to the subject a therapeutically effective amount of a GPR84 agonist. Further, the invention provides a method treating an immune system disease or disorder in a subject by administering to the subject a therapeutically effective amount of a GPR84 agonist. Also, the invention provides a method of modulating the immune system of a subject afflicted with or at risk of an immune system disease or disorder by administering to the subject a therapeutically effective amount of a GPR84 agonist.
摘要:
The disclosure provides for metal organic frameworks (MOFs) which comprise a plurality of SBUs linked together by functionalized or multivariate BTB-based linking ligands. The disclosure further provides for the use of these MOFs in variety of applications, including for gas separation, gas storage, catalysis, and separation of compounds or bioproducts.
摘要:
The present invention relates to Amorfrutin analogues and stereoisomeric forms, solvates, hydrates, conjugates and/or pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions containing at least one of these Amorfrutin analogues together with pharmaceutically acceptable carrier, excipient and/or diluents. Said Amorfrutin analogues have been identified as modulators of the peroxisome proliferator-activated receptors (PPARs), especially PPAR ϒ and are useful for the prevention and treatment of metabolic diseases, inflammatory diseases, cancer and preparation of phytomedicals and/or functional food products for prevention of metabolic diseases.
摘要:
Compounds of Formula I, wherein Ar, L, m, R 1 , R 2 , R 3 , W, X, Y, Z are as defined in the claims, are described that are active on at least one of PPARa, PPARd and PPAR?, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPARa, PPARd and PPAR?.
摘要:
The invention relates to chainlike polycyclic bisanhydrides, containing between 2 and 12 permanent-chain cyclenes, selected from 1,3-phenylene, 1,4-phenylene, 2,6-naphthylene, 2,7-naphthylene, 1,4-cyclohexylene, bicyclopentylene, bicyclooctylene, cubylene, which can be mono- or polysubstituted with halogen, cyano, alkyl, fluoralkyl, alkoxy and/or fluoralkoxy. Said cyclenes are linked by bridging groups, selected from a single bond, -CF2O, -OCF2-, -O-, -S-, -SO2-, -CO-, -NH-, -(CH2)1-10-, -(CF2)1-10-, -CH(CH3)-, -CH(CCI3)-, -CH(CF3)-, -C(CH3)2-, -C(CF3)2-, -CC-, -CH=CH-, -CF=CH-, -CH=CF-, -CF=CF- and the formulae in (I), with the proviso that at least one bridging group is -CF20- or -OCF2-. The polycyclenes are terminated at both ends of the chain by various groups, selected from the formulae in (II).
摘要:
The invention relates to compounds of formula (I) as well as the salts and stereoisomers thereof used to produce medicaments for the treatment of cardiovascular diseases.
摘要:
The invention relates to the use of compounds of formula (I) and of their salts and stereoisomers in the production of medicaments for treating cardiovascular diseases.